Developments in the screening for Chlamydia trachomatis:: a review

被引：27

作者：

Kohl, KS

Markowitz, LE

Koumans, EH

机构：

[1] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div STD Prevent, Atlanta, GA 30333 USA

[2] Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA

来源：

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2003年 / 30卷 / 04期

关键词：

SEXUALLY-TRANSMITTED-DISEASES; LIGASE-CHAIN-REACTION; PELVIC-INFLAMMATORY-DISEASE; FAMILY-PLANNING CLINICS; DNA AMPLIFICATION ASSAYS; FIRST-VOID URINE; NEISSERIA-GONORRHOEAE; COST-EFFECTIVENESS; UNITED-STATES; GENITOURINARY SPECIMENS;

D O I：

10.1016/S0889-8545(03)00076-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Screening for Chlamydia trachomatis infection remains an essential component of C trachomatis control. It is cost effective, most infections are asymptomatic, and symptom-based health care seeking and testing identify few infected individuals. Most studies and all guidelines recommend that all women aged < 25 be screened yearly for C trachomatis infection. The number of sex partners, new or more than one sex partners, and previous infection may serve as criteria for screening women aged > 25. Because re-infection rates are high and occur within a few months, ensuring that partners are treated and screening women four to six months after initial infection may further reduce complications.

引用

页码：637 / +

页数：23

共 117 条

[1] DECREASED PREVALENCE OF CHLAMYDIA-TRACHOMATIS INFECTION ASSOCIATED WITH A SELECTIVE SCREENING-PROGRAM IN FAMILY-PLANNING CLINICS IN WISCONSIN [J].